IL183526A0
(en )
2007-09-20
4-(4-(imidazol-4-yl)pyrimidin-2-ylamino)benzamides as cdk inhibitors
EP1753428A4
(en )
2010-09-15
Kinase inhibitors as therapeutic agents
ZA200606683B
(en )
2008-01-30
Pyrazolotriazines as kinase inhibitors
ZA200606573B
(en )
2009-10-28
Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
IL181169A0
(en )
2007-07-04
Trifluoromethyl substituted benzamides as kinase inhibitors
ZA200606152B
(en )
2007-11-28
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
HK1199254A1
(en )
2015-06-26
Process for the preparation of aurora kinase inhibitors
EP1794137A4
(en )
2009-12-02
Specific kinase inhibitors
ZA200701281B
(en )
2008-12-31
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
IL180872A0
(en )
2007-07-04
Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
ZA200608221B
(en )
2008-08-27
Thiadlazolidinones as GSK-3 Inhibitors
IL173381A0
(en )
2006-06-11
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
ZA200704106B
(en )
2009-09-30
Inhibitors of c-fms kinase
IL179613A0
(en )
2007-05-15
Compounds and compositions as protein kinase inhibitors
PL1713806T3
(en )
2013-09-30
Compounds and compositions as protein kinase inhibitors
IL182687A0
(en )
2007-09-20
Compounds and compositions as protein kinase inhibitors
IL181466A0
(en )
2007-07-04
Pulmonary delivery of inhibitors of phosphodiesterase type 5
EP1756092A4
(en )
2009-12-02
Novel inhibitors of rho-kinases
PT1763517E
(en )
2011-07-01
Pyrimidine derivatives as 11beta-hsd1 inhibitors
EP1778693A4
(en )
2009-11-11
Tricyclic-heteroaryl compounds useful as kinase inhibitors
SI1713805T1
(en )
2009-10-31
Kinase inhibitors
EP1765820A4
(en )
2010-07-21
Compounds and compositions as protein kinase inhibitors
EP1713793A4
(en )
2009-09-02
Pyrimidinone compounds useful as kinase inhibitors
IL182735A0
(en )
2007-09-20
Inhibitors of c-fms kinase
ZA200703130B
(en )
2008-07-30
Compounds and compositions as protein kinase inhibitors